Medicare coverage of outpatient ambulatory intravenous antibiotic therapy: A program that pays for itself

Clinical Infectious Diseases

Volumn 27, Issue 6, 1998, Pages 1415-1421

  Tice, Alan D ^a   Poretz, Donald ^a   Cook, Francesca ^a   Zinner, Darren ^a   Strauss, Michael J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CELLULITIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG SAFETY; ENDOCARDITIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MEDICARE; OSTEOMYELITIS; OUTPATIENT CARE; PNEUMONIA; PRIORITY JOURNAL;

EID: 0032458774     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515028     Document Type: Article

References (21)

1. Winters RW. Home infusion therapy industry: an overview. In: Conners RB, Winters RW, eds. Home infusion therapy: current status and future trends. Chicago: American Hospital Publishing, 1995:1-15.
2. Craig WA. Kinetics of antibiotics in relation to effective and convenient outpatient parenteral therapy. Int J Antimicrob Agents 1995; 5:19-22.
3. Gilbert DN, Dworkin R, Raber SR, Leggett JE. Outpatient parenteral antimicrobial-drug therapy. N Engl J Med 1997; 337:829-38.
4. Tice AD, ed. Handbook of outpatient parenteral therapy for infectious diseases. Scientific American Medicine. New York: Scientific American, 1997.
5. Tice AD. Alternate site infusion: the physician-directed, office-based model. J Intraven Nurs 1996; 19:188-93.
6. Poretz DM, Eron LJ, Goldenberg RI, et al. Intravenous antibiotic therapy in an outpatient setting. JAMA 1982; 248:336-9.
7. Stiver HG, Telford GO, Mossey JM, et al. Intravenous antibiotic therapy at home. Ann Intern Med 1978; 89:690-3.
8. Martone WJ, Jarvis W, Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachman PS, eds. Hospital infections. 3rd ed. Boston: Little, Brown & Co., 1992: 577-96.
9. Fine MJ, Singer DE, Marrie TJ, et al. Medical outcomes of ambulatory and hospitalized low risk patients with community-acquired pneumonia. J Gen Intern Med 1994; 9(Apr suppl 2):29A.
10. Dalovisio JR, Dodd K. OPAT, the physician, and the nurse specialist in managed care. In: Outpatient parenteral antimicrobial therapy: current status. Scientific American Medicine. New York: Scientific American, 1997; July:22-7.
11. Kunkel MJ. Outpatient treatment of endocarditis. In: Outpatient parenteral antimicrobial therapy: current status. Scientific American Medicine. New York: Scientific American, 1997; July:60-4.
12. Stamboulian D. Outpatient treatment of endocarditis in a clinic-based program in Argentina. Eur J Clin Microbiol Infect Dis 1995; 14: 16-22.
13. Powers RD. Infections of skin and soft tissue. In: Outpatient parenteral antimicrobial therapy: current status. Scientific American Medicine. New York: Scientific American, 1997; July:65-8.
14. Tice AD. Osteomyelitis. In: Outpatient parenteral antimicrobial therapy: current status. Scientific American Medicine. New York: Scientific American, 1997; July:55-9.
15. New PB, Swanson GF, Bulich RG, Taplin GC. Ambulatory antibiotic infusion devices: extending the spectrum of outpatient therapies. Am J Med 1991; 91:455-61.
16. Dalovisio JR. OPAT for community-acquired pneumonia. In: Outpatient parenteral antimicrobial therapy: current status. Scientific American Medicine. New York: Scientific American, 1997; July:69-72.
17. Fine MJ, Medsger AR, Stone RA, et al. The hospital discharge decision for patients with community-acquired pneumonia. Arch Intern Med 1997; 157:47-56.
18. Prospective Payment Assessment Commission (ProPAC). An analysis of outlier payments: Rand Study. Washington D.C.: Pro PAC, March, 1990:xiv.
19. Hindes R, Winkler C, Kane P, Kunkel M. Outpatient intravenous antibiotic therapy in Medicare patients: cost-savings analysis. Infect Dis Clin Pract 1995; 4:211-7.
20. Kane RE, Jennison K, Wood C, Black PG, Herbst JJ. Cost savings and economic considerations using home intravenous antibiotic therapy for cystic fibrosis patients. Pediatr Pulmonol 1988; 4:84-9.
21. Williams DN, Bosch D, Boots J, Schneider J. Safety, efficacy, and cost savings in an outpatient intravenous antibiotic program. Clin Ther 1993; 15:169-79.